Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 pivotal study evaluating the efficacy of Lorundrostat in subjects with uncontrolled hypertension on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorundrostat (lorundrostat)

Snippet

Sponsor: Mineralys Therapeutics Inc. | Conditions: Hypertension | Phase 2 | Status: COMPLETED